Journal of Pediatric Epilepsy 2017; 06(02): 097-102
DOI: 10.1055/s-0037-1599189
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Comparison of Perioperative Costs between Stereotactic Laser Ablation and Craniotomy for Hypothalamic Hamartoma

Sandi Lam
1   Department of Neurosurgery, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, United States
,
Caroline Hadley
1   Department of Neurosurgery, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, United States
,
Daniel J. Curry
1   Department of Neurosurgery, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, United States
,
I-Wen Pan
1   Department of Neurosurgery, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, United States
› Author Affiliations
Further Information

Publication History

04 May 2016

03 June 2016

Publication Date:
02 March 2017 (online)

Abstract

Hypothalamic hamartoma (HH) is a congenital intracranial lesion associated with precocious puberty and gelastic epilepsy in children. Surgical management of HH to treat refractory epilepsy is a mainstay of treatment. Our aim was to compare the demographic characteristics and perioperative costs associated with resection by craniotomy and stereotactic laser ablation (SLA) by reviewing our institutional experience with SLA and comparing these data to a national database for craniotomy and resection. Retrospective chart review was conducted for the Texas Children's Hospital cohort of patients who underwent SLA for HH between 2011 and 2013. Information about the craniotomy cohort representing historical cases of craniotomy was obtained from the Kids' Inpatient Database for years 2003, 2006, and 2009. The cohort definition for patients undergoing craniotomy for HH was modified from published adult literature to identify pediatric patients with refractory epilepsy secondary to HH. Our study has shown that children undergoing SLA for HH have a shorter length of stay and lower cost of hospitalization compared with those who underwent craniotomy and resection for the same diagnosis. Together with previous findings from our institution regarding the safety and efficacy of SLA, our findings suggest that SLA may represent an attractive alternative to craniotomy for the treatment of refractory epilepsy secondary to HH.

 
  • References

  • 1 Pati S, Sollman M, Fife TD, Ng YT. Diagnosis and management of epilepsy associated with hypothalamic hamartoma: an evidence-based systematic review. J Child Neurol 2013; 28 (7) 909-916
  • 2 Brandberg G, Raininko R, Eeg-Olofsson O. Hypothalamic hamartoma with gelastic seizures in Swedish children and adolescents. Eur J Paediatr Neurol 2004; 8 (1) 35-44
  • 3 Shahar E, Kramer U, Mahajnah M , et al. Pediatric-onset gelastic seizures: clinical data and outcome. Pediatr Neurol 2007; 37 (1) 29-34
  • 4 Nguyen D, Singh S, Zaatreh M , et al. Hypothalamic hamartomas: seven cases and review of the literature. Epilepsy Behav 2003; 4 (3) 246-258
  • 5 Jung H, Neumaier Probst E, Hauffa BP, Partsch CJ, Dammann O. Association of morphological characteristics with precocious puberty and/or gelastic seizures in hypothalamic hamartoma. J Clin Endocrinol Metab 2003; 88 (10) 4590-4595
  • 6 Kerrigan JF, Ng YT, Chung S, Rekate HL. The hypothalamic hamartoma: a model of subcortical epileptogenesis and encephalopathy. Semin Pediatr Neurol 2005; 12 (2) 119-131
  • 7 Maixner W. Hypothalamic hamartomas—clinical, neuropathological and surgical aspects. Childs Nerv Syst 2006; 22 (8) 867-873
  • 8 Mittal S, Mittal M, Montes JL, Farmer JP, Andermann F. Hypothalamic hamartomas. Part 1. Clinical, neuroimaging, and neurophysiological characteristics. Neurosurg Focus 2013; 34 (6) E6 DOI: 10.3171/2013.3.FOCUS1355.
  • 9 Berkovic SF, Arzimanoglou A, Kuzniecky R, Harvey AS, Palmini A, Andermann F. Hypothalamic hamartoma and seizures: a treatable epileptic encephalopathy. Epilepsia 2003; 44 (7) 969-973
  • 10 Wilfong AA, Curry DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia 2013; 54 (Suppl. 09) 109-114
  • 11 Mittal S, Mittal M, Montes JL, Farmer JP, Andermann F. Hypothalamic hamartomas. Part 2. Surgical considerations and outcome. Neurosurg Focus 2013; 34 (6) E7 DOI: 10.3171/2013.3.FOCUS1356.
  • 12 Northfield DW, Russell DS. Pubertas praecox due to hypothalamic hamartoma: report of two cases surviving surgical removal of the tumour. J Neurol Neurosurg Psychiatry 1967; 30 (2) 166-173
  • 13 Polkey CE. Resective surgery for hypothalamic hamartoma. Epileptic Disord 2003; 5 (4) 281-286
  • 14 Rekate HL, Feiz-Erfan I, Ng YT, Gonzalez LF, Kerrigan JF. Endoscopic surgery for hypothalamic hamartomas causing medically refractory gelastic epilepsy. Childs Nerv Syst 2006; 22 (8) 874-880
  • 15 Régis J, Scavarda D, Tamura M , et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Semin Pediatr Neurol 2007; 14 (2) 73-79
  • 16 Calisto A, Dorfmüller G, Fohlen M, Bulteau C, Conti A, Delalande O. Endoscopic disconnection of hypothalamic hamartomas: safety and feasibility of robot-assisted, thulium laser-based procedures. J Neurosurg Pediatr 2014; 14 (6) 563-572
  • 17 de Almeida AN, Fonoff ET, Ballester G, Teixeira MJ, Marino Jr R. Stereotactic disconnection of hypothalamic hamartoma to control seizure and behavior disturbance: case report and literature review. Neurosurg Rev 2008; 31 (3) 343-349
  • 18 Romanelli P, Muacevic A, Striano S. Radiosurgery for hypothalamic hamartomas. Neurosurg Focus 2008; 24 (5) E9 DOI: 10.3171/FOC/2008/24/5/E9.
  • 19 Tovar-Spinoza Z, Carter D, Ferrone D, Eksioglu Y, Huckins S. The use of MRI-guided laser-induced thermal ablation for epilepsy. Childs Nerv Syst 2013; 29 (11) 2089-2094
  • 20 Curry DJ, Gowda A, McNichols RJ, Wilfong AA. MR-guided stereotactic laser ablation of epileptogenic foci in children. Epilepsy Behav 2012; 24 (4) 408-414
  • 21 Kuzniecky R, Guthrie B, Mountz J , et al. Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol 1997; 42 (1) 60-67
  • 22 Parrent AG. Stereotactic radiofrequency ablation for the treatment of gelastic seizures associated with hypothalamic hamartoma. Case report. J Neurosurg 1999; 91 (5) 881-884
  • 23 Wait SD, Abla AA, Killory BD, Nakaji P, Rekate HL. Surgical approaches to hypothalamic hamartomas. Neurosurg Focus 2011; 30 (2) E2 DOI: 10.3171/2010.11.FOCUS10250.
  • 24 Mukherjee D, Carico C, Nuño M, Patil CG. Predictors of inpatient complications and outcomes following surgical resection of hypothalamic hamartomas. Surg Neurol Int 2011; 2: 105 DOI: 10.4103/2152-7806.83387.
  • 25 HCUP Cost-to-Charge Ratio Files. 2009 Kids' Inpatient Database User Guide; 2011. Available at http://legacy-hhsc.hhsc.state.tx.us/rad/hospital-svcs/inp-outp-previous-rates.shtml . Accessed June 15, 2014
  • 26 Inpatient and Outpatient Ratio of Cost to Charges (RCC Rates) 2013. http://www.hhsc.state.tx.us/rad/hospital-svcs/inp-outp-previous-rates.shtml . Accessed June 15, 2014
  • 27 International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). http://www.cdc.gov/nchs/icd/icd9cm.htm . Accessed January 6, 2014
  • 28 Introduction to the HCUP KIDS inpatient database 2009; 2011. http://www.hcup-us.ahrq.gov/db/nation/kid/KID_2009_Introduction.pdf . Accessed January 6, 2014
  • 29 Baca CB, Vickrey BG, Vassar S , et al. Time to pediatric epilepsy surgery is related to disease severity and nonclinical factors. Neurology 2013; 80 (13) 1231-1239
  • 30 Hauptman JS, Dadour A, Oh T , et al. Time to pediatric epilepsy surgery is longer and developmental outcomes lower for government compared with private insurance. Neurosurgery 2013; 73 (1) 152-157
  • 31 Thomas JW, Guire KE, Horvat GG. Is patient length of stay related to quality of care?. Hosp Health Serv Adm 1997; 42 (4) 489-507
  • 32 Alexander III E, Moriarty TM, Davis RB , et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995; 87 (1) 34-40